Skip to content

Feasibility Study of High Intensity Focused Ultrasound on Follicular Activation in Women with Refractory Ovulatory Infertility

Feasibility Study of High Intensity Focused Ultrasound on Follicular Activation in Women with Refractory Ovulatory Infertility

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050385
Enrollment
Unknown
Registered
2021-08-27
Start date
2021-08-23
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovulatory Infertility

Interventions

Simple group:High-intensity focused ultrasound
Integrated group:High-intensity focused ultrasound (ovarian and uterine fibroids)

Sponsors

Shanghai Xuhui Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with ovulatory dysfunction aged >= 25 years, priority included in the diagnosis of premature ovarian insufficiency, refractory polycystic ovary syndrome (unilateral or bilateral ovarian diameter 2-9 mm follicles >= 20-30); 2. Not pregnant after receiving specialized treatment in reproductive center for more than 1 year; 3. Routine ovulation induction therapy, two cycles of treatment for anovulatory or oocyte retrieval 40 IU/L,FSH/LH > 2-3, antral follicle count(AFC) < 3-6 serum, anti-mullerian hormone(AMH) < 1 ng/ml; 6. Patients with irregular uterine bleeding and hyperandrogenemia and/or clinical manifestations of polycystic ovarian changes; 7. Patients with adenomyosis complicated with uterine fibroids.

Exclusion criteria

Exclusion criteria: 1. Infertility caused by fallopian tube,reproductive tract malformation,immune factors and other reasons; 2. Patients with hypothalamus and/or hypophysis, such as hypogonadotropin sex hypogonadism; 3. Complicated with cardiovascular,cerebrovascular,liver,kidney and hematopoietic system and other major diseases and abnormal secretion function of adrenal and thyroid glands; 4. Patients with hyperprolactinemia; 5. Patients with a history of abdominal surgery; 6. Patients with a history of pelvic inflammatory disease; 7. Patients with poor treatment compliance.

Design outcomes

Primary

MeasureTime frame
Pregnancy rate;Ovulation rate;

Secondary

MeasureTime frame
Sex hormone;Ovarian reserve;

Countries

China

Contacts

Public ContactXu Yonghua

Shanghai Xuhui Central Hospital

yhxu@scrc.ac.cn+86 13817554049

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026